We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
(-9.9%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$26.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$19.8M |
| 4 |
Morgan Stanley
MS
|
+$18.5M |
| 5 |
Kraft Heinz
KHC
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$22.3M |
| 2 |
Amgen
AMGN
|
+$21.9M |
| 3 |
Alibaba
BABA
|
+$18.9M |
| 4 |
SLB Ltd
SLB
|
+$18M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.76% |
| 2 | Technology | 13.33% |
| 3 | Consumer Discretionary | 12.45% |
| 4 | Industrials | 11.02% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
876
DELISTED
PDL BioPharma, Inc.
PDLI
| $501K | 0.02% |
99,661
-253,011
| -72% | -$1.45M |
|
|
EDR
877
DELISTED
Education Realty Trust Inc
EDR
| $499K | 0.02% |
15,160
-31,859
| -68% | -$989K |
|
|
BIN
878
DELISTED
PROGRESSIVE WASTE SOLUTIONS LTD COM
BIN
| $499K | 0.02% |
18,923
-300
| -2% | -$7.98K |
|
|
AOI
879
DELISTED
Alliance One International
AOI
| $497K | 0.02% |
+24,423
| New | +$553K |
|
880
Arcturus Therapeutics
ARCT
$165M
| $492K | 0.02% |
+11,653
| New | +$613K |
|
|
HCBK
881
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $491K | 0.02% |
48,359
| – | – |
|
|
GTLS
882
DELISTED
Chart Industries
GTLS
| $487K | 0.02% |
25,403
-47,840
| -65% | -$1.26M |
|
|
LTXB
883
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $487K | 0.02% |
15,993
-34,713
| -68% | -$1.01M |
|
|
DNR
884
DELISTED
Denbury Resources, Inc.
DNR
| $485K | 0.02% |
198,953
-261,702
| -57% | -$1.01M |
|
885
CDW
CDW
$18.9B
| $482K | 0.02% |
+11,805
| New | +$447K |
|
886
Cooper Companies
COO
$14.2B
| $480K | 0.02% |
+12,908
| New | +$535K |
|
|
EFII
887
DELISTED
Electronics for Imaging
EFII
| $478K | 0.02% |
11,046
-7,893
| -42% | -$351K |
|
888
Restaurant Brands International
QSR
$26.2B
| $476K | 0.02% |
13,264
-50,329
| -79% | -$1.99M |
|
|
IMPR
889
DELISTED
IMPRIVATA, INC COM
IMPR
| $475K | 0.02% |
26,766
+16,406
| +158% | +$293K |
|
|
SIVB
890
DELISTED
SVB Financial Group
SIVB
| $475K | 0.02% |
4,113
-11,452
| -74% | -$1.53M |
|
|
PGRE
891
DELISTED
Paramount Group
PGRE
| $473K | 0.02% |
28,178
-19,689
| -41% | -$340K |
|
|
BGC
892
DELISTED
General Cable Corporation
BGC
| $473K | 0.02% |
39,781
-57,646
| -59% | -$898K |
|
|
HPY
893
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $472K | 0.02% |
+7,493
| New | +$446K |
|
894
Chesapeake Utilities
CPK
$3.28B
| $471K | 0.02% |
+8,888
| New | +$453K |
|
895
Otter Tail
OTTR
$3.81B
| $471K | 0.02% |
18,089
+4,192
| +30% | +$111K |
|
|
ACC
896
DELISTED
American Campus Communities, Inc.
ACC
| $470K | 0.02% |
12,982
+2,855
| +28% | +$104K |
|
897
Build-A-Bear
BBW
$445M
| $469K | 0.02% |
24,865
-1,649
| -6% | -$31.2K |
|
898
CMS Energy
CMS
$23B
| $467K | 0.02% |
13,230
-13,502
| -51% | -$455K |
|
899
Immersion
IMMR
$243M
| $464K | 0.02% |
+41,401
| New | +$502K |
|
900
Tyler Technologies
TYL
$13.7B
| $463K | 0.02% |
3,107
-7,687
| -71% | -$1.08M |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
- A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
- A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
- A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
- A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
- A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
- A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
- A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.
Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.